There was not significant difference between salidroside group and sham operation group P > 0.05.
红景天苷药物组与假手术组比较，差异不明显（P>0.05）。
The two treatment groups had difference(P<0.05) or obvious difference with model group(P<0.01).
各治疗组与模型组相比有差异（P<0.05）或显著差异（P<0.01）；
Results: The clinic efficacy of pueraria group was better than that of control group (P<0.05).
结果：葛根素组的治疗效果优于对照组（P<0.05）。
Result:The total effective rate was 80% in treatment group and 67% in control group, P< 0.05.
结果治疗组有效率为80%，对照组有效率为67%（P<0.05）。 结论疏肝活血利水法治疗难治性青光眼有显著疗效。
Results The total effective rate was 94.2% in treatment group and 78.1% in control group(P<0.05).
结果治疗组总有效率为94.2%，对照组为78.1%，差异有统计学意义（P<0.05）。
On improvement among them in tinnitus, cure obvious group better than contrasting a group(P<0.01).
其中在耳鸣的改善上，治疗组明显优于对照组（P<0.01）。
The tolerance of treatment group was better than the control group (P<0.05).
治疗组的耐受性优于对照组（P<0.05）。
Results:The treatment group increase in immunity obviously better than the control group(P<0.05);
结果：治疗组在提高机体免疫力方面明显优于对照组（P＜0.05）。
The treatment group was better than the control group (P<0.05).
治疗组优于对照组（P<0.05）。
Result Symptoms of the experimental group were obviously improved compared with the control group(P<0.05).
结果治疗组与对照组比较，突发性聋症状改善更显著（P<0.05）。
The asymmetry index in PD group was higher than that in ET group ( P<0.05).
非对称性指数：PD组高于ET组，差异有显著性（P<0.05）。
Medicine compliance in study group was higher than that of control group(P<0.01).
研究组服药依从性高于对照组，有显著性差异（P＜0.01）；
There was no significant difference between BYHWT-treated group and nimodipine-treated group(P>0.05).
尼莫地平组与补阳还五汤组之间差异无显著性（P>0.05）。
There was no difference between benazepril postconditioning group and preconditioning group (P>0.05).
苯那普利后处理组和预处理组相比较，差异无统计学意义（P>0.05）。
The survival time was significantly longer in PE group(P < 0.05).
而PE组生存期比对照组延长（P<0.05）。
Moreover, its level was remarkably lower in XZD group than in RT group (P<0.05).
而且，血府逐瘀汤组显著低于常规治疗组（P<0.05）。
The effects of therapy group were significantly better than that in control group, P<0.05.
治疗组与对照组比较治疗组效果明显优于对照组，差异有显著性，P<0.05。
Results:The efficacy was significantly better in treatment group than in control group(P<0.05).
结果：治疗组明显优于对照组（P<0.05）。
The resorption in test group was significantly lower than in control group (P<0.001).
实验组平均骨量吸收程度显著低于对照组（P<0.001）。
The duration of ICU stay was shorter than the control group(P<0.01).
治疗组ICU住院时间明显短于对照组（P<0.01）。
Results: The total effective rates were 72.2% and 67.6% in dexzopiclone and control group (P>0.05).
结果：治疗组和对照组总有效率分别为72.2%和 67.6%，组间比较无显著差异（P＞0.05）。
Results: The total effective rates were 72.2% and 67.6% in dexzopiclone and control group (P>0.05).
结果：治疗组和对照组总有效率分别为72.2%和 67.6%，组间比较无显著差异（P＞0.05）。
应用推荐